DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Creutzig U, Ritter J, Schellong G.
Identification of two risk groups in childhood acute myelogenous leukemia after therapy intensification in the study AML-BFM-83 as compared with study AML-BFM-78.
Blood 1990;
75: 1932-1940
We do not assume any responsibility for the contents of the web pages of other providers.